| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pertussis Vaccine | 6 | 2019 | 89 | 1.93 | Why? |
| Whooping Cough | 6 | 2019 | 201 | 1.89 | Why? |
| Lymphadenitis | 4 | 2017 | 53 | 1.55 | Why? |
| Stomatitis, Aphthous | 4 | 2017 | 43 | 1.52 | Why? |
| Palatine Tonsil | 2 | 2017 | 127 | 1.27 | Why? |
| Pharyngitis | 4 | 2017 | 687 | 1.15 | Why? |
| Bordetella pertussis | 3 | 2019 | 117 | 0.92 | Why? |
| Influenza Vaccines | 9 | 2019 | 2941 | 0.87 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2019 | 91 | 0.87 | Why? |
| Influenza, Human | 11 | 2021 | 10779 | 0.82 | Why? |
| Diphtheria Toxoid | 1 | 2018 | 6 | 0.78 | Why? |
| Community-Acquired Infections | 13 | 2018 | 2328 | 0.66 | Why? |
| Herpes Zoster Vaccine | 1 | 2018 | 112 | 0.64 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2017 | 492 | 0.62 | Why? |
| Systems Biology | 1 | 2017 | 320 | 0.54 | Why? |
| Vaccines, Attenuated | 2 | 2018 | 952 | 0.52 | Why? |
| Ebolavirus | 1 | 2020 | 834 | 0.49 | Why? |
| Herpes Zoster | 1 | 2018 | 331 | 0.49 | Why? |
| Fever | 5 | 2017 | 7795 | 0.48 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.42 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2018 | 2984 | 0.41 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.41 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.40 | Why? |
| Immunity, Cellular | 2 | 2020 | 3614 | 0.40 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.39 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2020 | 1475 | 0.39 | Why? |
| Metapneumovirus | 3 | 2018 | 465 | 0.38 | Why? |
| Paramyxoviridae Infections | 3 | 2018 | 364 | 0.37 | Why? |
| Adjuvants, Immunologic | 3 | 2017 | 1709 | 0.37 | Why? |
| Pregnancy | 10 | 2020 | 23879 | 0.36 | Why? |
| Respiratory Sounds | 2 | 2017 | 294 | 0.36 | Why? |
| Pneumococcal Infections | 3 | 2019 | 562 | 0.35 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2018 | 92 | 0.34 | Why? |
| Pneumonia, Bacterial | 4 | 2018 | 843 | 0.34 | Why? |
| Infant | 25 | 2018 | 30274 | 0.33 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.33 | Why? |
| Respiratory Tract Infections | 10 | 2019 | 6817 | 0.31 | Why? |
| Vaccination | 14 | 2020 | 19050 | 0.31 | Why? |
| Calcitonin | 2 | 2018 | 201 | 0.30 | Why? |
| Child, Preschool | 27 | 2021 | 36283 | 0.30 | Why? |
| Vaccines | 3 | 2020 | 3692 | 0.30 | Why? |
| Immunity, Maternally-Acquired | 2 | 2017 | 179 | 0.30 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.29 | Why? |
| Clinical Trials as Topic | 3 | 2020 | 7330 | 0.27 | Why? |
| Antibodies, Bacterial | 2 | 2018 | 510 | 0.27 | Why? |
| Antigen Presentation | 2 | 2017 | 524 | 0.26 | Why? |
| Croup | 1 | 2013 | 44 | 0.26 | Why? |
| Pneumonia | 6 | 2018 | 5652 | 0.26 | Why? |
| Streptococcus pneumoniae | 2 | 2019 | 827 | 0.25 | Why? |
| Child | 21 | 2021 | 70012 | 0.24 | Why? |
| Pertussis Toxin | 2 | 2018 | 19 | 0.24 | Why? |
| Syndrome | 2 | 2017 | 1310 | 0.23 | Why? |
| Africa, Western | 2 | 2020 | 363 | 0.23 | Why? |
| Alaska | 1 | 2021 | 100 | 0.23 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.22 | Why? |
| Immunization | 3 | 2021 | 2019 | 0.20 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.19 | Why? |
| Smallpox | 1 | 2020 | 96 | 0.19 | Why? |
| Bronchiolitis | 1 | 2013 | 297 | 0.19 | Why? |
| Viruses | 4 | 2018 | 2238 | 0.19 | Why? |
| Humans | 72 | 2021 | 930598 | 0.19 | Why? |
| Pregnancy Trimesters | 1 | 2019 | 90 | 0.19 | Why? |
| Toxoids | 1 | 2018 | 9 | 0.19 | Why? |
| Pregnancy Complications, Infectious | 4 | 2019 | 11559 | 0.19 | Why? |
| Serogroup | 2 | 2018 | 510 | 0.19 | Why? |
| Ebola Vaccines | 1 | 2020 | 126 | 0.19 | Why? |
| Neuralgia, Postherpetic | 1 | 2018 | 22 | 0.18 | Why? |
| Female | 41 | 2021 | 380317 | 0.18 | Why? |
| Tetanus | 1 | 2018 | 61 | 0.18 | Why? |
| Infectious Disease Medicine | 1 | 2021 | 311 | 0.18 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2018 | 1234 | 0.18 | Why? |
| Influenzavirus C | 1 | 2017 | 37 | 0.18 | Why? |
| Bocavirus | 1 | 2017 | 74 | 0.17 | Why? |
| Papio | 1 | 2018 | 104 | 0.17 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.17 | Why? |
| Prospective Studies | 17 | 2021 | 43301 | 0.17 | Why? |
| Medical Order Entry Systems | 1 | 2017 | 43 | 0.17 | Why? |
| Hereditary Autoinflammatory Diseases | 1 | 2017 | 72 | 0.16 | Why? |
| Child Health Services | 1 | 2003 | 520 | 0.16 | Why? |
| Submandibular Gland | 1 | 2016 | 29 | 0.16 | Why? |
| Sialorrhea | 1 | 2016 | 24 | 0.16 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2017 | 191 | 0.16 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.16 | Why? |
| Malaria Vaccines | 1 | 2017 | 90 | 0.16 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 104 | 0.16 | Why? |
| Adolescent | 16 | 2021 | 86841 | 0.16 | Why? |
| Pediatrics | 3 | 2021 | 2969 | 0.16 | Why? |
| Bacterial Vaccines | 1 | 2017 | 139 | 0.15 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.15 | Why? |
| Neuromuscular Agents | 1 | 2016 | 87 | 0.15 | Why? |
| Herpesvirus 3, Human | 1 | 2018 | 228 | 0.15 | Why? |
| Parvoviridae Infections | 1 | 2017 | 222 | 0.15 | Why? |
| beta-Lactams | 1 | 2017 | 210 | 0.15 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.14 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.14 | Why? |
| Sinus Thrombosis, Intracranial | 1 | 2021 | 550 | 0.14 | Why? |
| Drug Hypersensitivity | 1 | 2021 | 401 | 0.14 | Why? |
| Male | 35 | 2021 | 367725 | 0.14 | Why? |
| Cerebral Palsy | 1 | 2016 | 156 | 0.14 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.14 | Why? |
| Death | 1 | 2018 | 334 | 0.14 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.14 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.14 | Why? |
| Botulinum Toxins, Type A | 1 | 2016 | 134 | 0.14 | Why? |
| Ethics, Research | 1 | 2018 | 328 | 0.14 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.14 | Why? |
| Macrolides | 1 | 2017 | 369 | 0.14 | Why? |
| Tennessee | 3 | 2021 | 243 | 0.13 | Why? |
| Lipids | 1 | 2021 | 1079 | 0.13 | Why? |
| Nervous System Diseases | 2 | 2016 | 4092 | 0.13 | Why? |
| Caliciviridae Infections | 1 | 2017 | 229 | 0.13 | Why? |
| Orthomyxoviridae | 1 | 2002 | 1168 | 0.13 | Why? |
| Professional-Family Relations | 1 | 2018 | 424 | 0.13 | Why? |
| Rheumatologists | 1 | 2017 | 346 | 0.13 | Why? |
| United States | 12 | 2021 | 46150 | 0.12 | Why? |
| Emergencies | 2 | 2018 | 4095 | 0.12 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.12 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.12 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.12 | Why? |
| Chemokine CXCL10 | 1 | 2017 | 565 | 0.12 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2018 | 13720 | 0.12 | Why? |
| Adult | 20 | 2021 | 244371 | 0.12 | Why? |
| Drug Industry | 1 | 2020 | 689 | 0.12 | Why? |
| Pediatricians | 1 | 2017 | 401 | 0.12 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 694 | 0.12 | Why? |
| Infant, Newborn | 9 | 2018 | 23105 | 0.12 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.11 | Why? |
| Rhinovirus | 1 | 2017 | 979 | 0.11 | Why? |
| Data Collection | 2 | 2021 | 1769 | 0.11 | Why? |
| Diagnostic Tests, Routine | 3 | 2018 | 2643 | 0.11 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.11 | Why? |
| Attitude of Health Personnel | 2 | 2021 | 4741 | 0.11 | Why? |
| Immunization Schedule | 1 | 2018 | 1305 | 0.11 | Why? |
| Intestines | 1 | 2017 | 817 | 0.11 | Why? |
| Radiography, Thoracic | 2 | 2017 | 5486 | 0.10 | Why? |
| Deglutition Disorders | 1 | 2016 | 481 | 0.10 | Why? |
| International Cooperation | 2 | 2020 | 3436 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| Killer Cells, Natural | 2 | 2017 | 2093 | 0.10 | Why? |
| Cranial Nerve Diseases | 1 | 2011 | 148 | 0.10 | Why? |
| Vaccination Refusal | 1 | 2018 | 831 | 0.10 | Why? |
| Asymptomatic Diseases | 2 | 2019 | 3444 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.09 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.09 | Why? |
| Encephalomyelitis, Acute Disseminated | 1 | 2011 | 157 | 0.09 | Why? |
| Coinfection | 2 | 2019 | 6820 | 0.09 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.09 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.09 | Why? |
| Exanthema | 1 | 2018 | 1097 | 0.09 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.09 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2017 | 11367 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Asthma | 2 | 2017 | 4383 | 0.08 | Why? |
| Monocytes | 2 | 2017 | 2978 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Respiratory System | 3 | 2015 | 3213 | 0.08 | Why? |
| Feces | 2 | 2017 | 4235 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Hospitalization | 9 | 2018 | 54280 | 0.08 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Immunogenicity, Vaccine | 2 | 2018 | 4624 | 0.08 | Why? |
| Acute Disease | 5 | 2017 | 6029 | 0.08 | Why? |
| Pregnant Women | 1 | 2019 | 2535 | 0.07 | Why? |
| Schools | 1 | 2021 | 4187 | 0.07 | Why? |
| Smallpox Vaccine | 1 | 2005 | 46 | 0.07 | Why? |
| Practice Patterns, Physicians' | 3 | 2018 | 4927 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Infant Welfare | 1 | 2003 | 17 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.07 | Why? |
| Maternal Welfare | 1 | 2003 | 40 | 0.07 | Why? |
| Rural Population | 1 | 2016 | 2408 | 0.07 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.06 | Why? |
| Neutrophils | 2 | 2017 | 5476 | 0.06 | Why? |
| Antibody Formation | 1 | 2017 | 4038 | 0.06 | Why? |
| Vaccines, Inactivated | 2 | 2018 | 1562 | 0.06 | Why? |
| Nasopharynx | 2 | 2019 | 10224 | 0.06 | Why? |
| Peru | 2 | 2017 | 1010 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.06 | Why? |
| Population Surveillance | 2 | 2017 | 4967 | 0.06 | Why? |
| Public Health | 2 | 2018 | 16359 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Aged | 12 | 2018 | 215776 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2018 | 51949 | 0.05 | Why? |
| Ambulatory Care | 1 | 2018 | 4947 | 0.05 | Why? |
| Vaccines, Acellular | 1 | 2019 | 12 | 0.05 | Why? |
| Insurance, Health, Reimbursement | 1 | 2021 | 205 | 0.05 | Why? |
| Health Care Surveys | 2 | 2021 | 2942 | 0.05 | Why? |
| Neonatologists | 1 | 2018 | 18 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Virus Diseases | 1 | 2016 | 3779 | 0.05 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.05 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.05 | Why? |
| Virulence Factors, Bordetella | 1 | 2017 | 14 | 0.05 | Why? |
| Control Groups | 1 | 2018 | 49 | 0.04 | Why? |
| Practice Guidelines as Topic | 3 | 2017 | 15421 | 0.04 | Why? |
| Guillain-Barre Syndrome | 1 | 2011 | 1495 | 0.04 | Why? |
| Apnea | 1 | 2018 | 58 | 0.04 | Why? |
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 39 | 0.04 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2017 | 60 | 0.04 | Why? |
| Maternal-Child Health Services | 1 | 2019 | 124 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2002 | 1132 | 0.04 | Why? |
| Mast Cells | 1 | 2021 | 370 | 0.04 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.04 | Why? |
| Infant, Low Birth Weight | 1 | 2018 | 243 | 0.04 | Why? |
| Coronavirus | 3 | 2012 | 18339 | 0.04 | Why? |
| Antipyretics | 1 | 2017 | 107 | 0.04 | Why? |
| Birth Weight | 1 | 2018 | 250 | 0.04 | Why? |
| Urinalysis | 1 | 2018 | 218 | 0.04 | Why? |
| Demography | 1 | 2013 | 1660 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Histamine H2 Antagonists | 1 | 2017 | 111 | 0.04 | Why? |
| Zambia | 1 | 2017 | 401 | 0.04 | Why? |
| Membrane Glycoproteins | 1 | 2005 | 2273 | 0.04 | Why? |
| Tonsillectomy | 1 | 2017 | 115 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Treatment Outcome | 6 | 2018 | 51732 | 0.04 | Why? |
| Injections | 1 | 2016 | 237 | 0.04 | Why? |
| Length of Stay | 3 | 2017 | 11042 | 0.04 | Why? |
| Platelet Count | 1 | 2021 | 1381 | 0.04 | Why? |
| Bradycardia | 1 | 2018 | 292 | 0.03 | Why? |
| Fetal Blood | 1 | 2017 | 573 | 0.03 | Why? |
| Enterobacteriaceae | 1 | 2017 | 395 | 0.03 | Why? |
| Nepal | 1 | 2017 | 1004 | 0.03 | Why? |
| Specialization | 1 | 2017 | 432 | 0.03 | Why? |
| Norovirus | 1 | 2017 | 294 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Altitude | 1 | 2016 | 311 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2018 | 749 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.03 | Why? |
| Education | 1 | 2017 | 434 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.03 | Why? |
| RNA, Viral | 2 | 2017 | 32276 | 0.03 | Why? |
| Vomiting | 1 | 2017 | 722 | 0.03 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.03 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.03 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.03 | Why? |
| Respiratory Syncytial Viruses | 1 | 2015 | 612 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2017 | 22971 | 0.03 | Why? |
| Headache | 1 | 2021 | 2257 | 0.03 | Why? |
| Intensive Care Units, Pediatric | 1 | 2017 | 1098 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2016 | 1182 | 0.03 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.02 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Protein Interaction Maps | 1 | 2017 | 1333 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2005 | 4606 | 0.02 | Why? |
| Oropharynx | 1 | 2017 | 1581 | 0.02 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.02 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.02 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2005 | 5837 | 0.02 | Why? |
| DNA Primers | 1 | 2012 | 1170 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.02 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Prenatal Care | 1 | 2017 | 1314 | 0.02 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2017 | 1792 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2017 | 48226 | 0.02 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Family Characteristics | 1 | 2016 | 2551 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.02 | Why? |
| Antigens, Viral | 2 | 2018 | 6298 | 0.02 | Why? |
| Nose | 1 | 2012 | 1093 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Pore Forming Cytotoxic Proteins | 1 | 2005 | 45 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Granzymes | 1 | 2005 | 197 | 0.02 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.02 | Why? |
| Perforin | 1 | 2005 | 136 | 0.02 | Why? |
| Pharynx | 1 | 2012 | 1544 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Developing Countries | 1 | 2019 | 4283 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Vaccinia virus | 1 | 2005 | 346 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Respiration, Artificial | 2 | 2017 | 22116 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.01 | Why? |
| In Vitro Techniques | 1 | 2005 | 1027 | 0.01 | Why? |
| Immunoassay | 1 | 2017 | 4485 | 0.01 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.01 | Why? |
| Coronavirus OC43, Human | 1 | 2009 | 1157 | 0.01 | Why? |
| Coronavirus 229E, Human | 1 | 2009 | 1241 | 0.01 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| T-Lymphocyte Subsets | 1 | 2005 | 1387 | 0.01 | Why? |
| Flow Cytometry | 1 | 2005 | 2393 | 0.01 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.01 | Why? |
| Lymphocyte Activation | 1 | 2005 | 2742 | 0.01 | Why? |
| Logistic Models | 1 | 2009 | 9089 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Age Factors | 1 | 2015 | 21039 | 0.01 | Why? |
| Phenotype | 1 | 2005 | 4037 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Immunologic Memory | 1 | 2005 | 3362 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.01 | Why? |
| Retrospective Studies | 1 | 2016 | 105322 | 0.00 | Why? |